Baxter/Allegiance/Premier purchasing deal to generate $1 bil. in annual sales.
This article was originally published in The Gray Sheet
Executive Summary
BAXTER, PREMIER DISCUSSING CARDIOVASCULAR PRODUCTS SUPPLY CONTRACT, building on a seven-year agreement covering medical and surgical devices signed Nov. 14 by Baxter Healthcare, Baxter spin-off Allegiance Healthcare and Premier, a hospital and health system alliance. The broad supply agreement, scheduled to take effect Feb. 1, 1997, is estimated to be worth approximately $1 bil. in annual sales. Baxter's cardiovascular revenues accounted for approximately 14% ($730 mil.) of total 1995 sales of $5.048 bil.